Key result
A mutant natriuretic peptide receptor-A (NPR-A-6E) engineered to mimic a fully phosphorylated state was activated 10-fold by ANP and ATP and demonstrated marked resistance to desensitization.
Engineering a constitutively 'phosphorylated' NPR-A mutant demonstrated that dephosphorylation is an essential component of homologous desensitization in response to ANP.
Dephosphorylation is essential for NPR-A desensitization; leaves open whether this mechanism can be targeted therapeutically in humans.
Dephosphorylation of the natriuretic peptide receptor-A (NPR-A) is hypothesized to mediate its desensitization in response to atrial natriuretic peptide (ANP) binding. Recently, we identified six phosphorylation sites within the kinase homology domain of NPR-A and determined that the conversion of these residues to alanine abolished the ability of the receptor to be phosphorylated or to be activated by ANP and ATP. In an attempt to generate a form of NPR-A that mimics a fully phosphorylated receptor but that is resistant to dephosphorylation, we engineered a receptor variant (NPR-A-6E) containing glutamate substitutions at all six phosphorylation sites. Consistent with the known ability of negatively charged glutamate residues to substitute functionally, in some cases, for phosphorylated residues, we found that NPR-A-6E was activated 10-fold by ANP and ATP. As determined by guanylyl cyclase assays, the hormone-stimulated activity of the wild-type receptor declined over time in membrane preparations in vitro, and this loss was blocked by the serine/threonine protein phosphatase inhibitor microcystin. In contrast, the activity of NPR-A-6E was more linear with time and was unaffected by microcystin. The nonhydrolyzable ATP analogue adenosine 5'-(beta,gamma-imino)-triphosphate was half as effective as ATP in stimulating the wild-type receptor but was equally as potent in stimulating NPR-A-6E, suggesting that ATP is required to keep the wild-type but not 6E variant phosphorylated. Finally, the desensitization of NPR-A-6E in whole cells was markedly blunted compared with that of the wild-type receptor, consistent with its inability to shed the negative charge from its kinase homology domain via dephosphorylation. These data provide the first direct test of the requirement for dephosphorylation in guanylyl cyclase desensitization and they indicate that it is an essential component of this process.
No takes yet. Share an insight, caveat, or question.
Potter et al. (1999) studied this question. NPR-A-6E mutant vs. Wild-type NPR-A was evaluated on Guanylyl cyclase activity and desensitization. A mutant natriuretic peptide receptor-A (NPR-A-6E) engineered to mimic a fully phosphorylated state was activated 10-fold by ANP and ATP and demonstrated marked resistance to desensitization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: